By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – AB Sciex today announced a collaboration with researchers at the University of Melbourne to develop standardized testing methodologies for the study of biopharmaceutical metabolism.

The project will be based on an approach developed by scientists at the university on the AB Sciex QTrap 5500 system to evaluate how protein-based drugs break down in vivo, something that drug discovery researchers currently cannot do.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The National Institute of General Medical Sciences director says changes the agency made have allow it to boost success rates.

Ancient DNA indicates Stone Age, hunter-gather inhabitants of Britain imported wheat.

Joel Achenbach explores at National Geographic why people find science difficult to believe.

In Science this week: gene linked to expansion of the human neocortex, and more.

Mar
05
Sponsored by
SomaLogic

In this live webcast, Robert Gerszten of Massachusetts General Hospital will describe an ongoing project that is integrating metabolic and proteomic profiling to gain a better understanding of cardiometabolic disease.